AEON Biopharma says underwriters fully exercise milestone warrant over-allotment option for 6,403,290 shares

• AEON Biopharma issued 4,696,102 Class A shares in a partial over-allotment exercise tied to its July 15 public offering.
• Transaction delivered about $1.5 million in gross proceeds, about $1.4 million net of underwriting discounts and commissions.
• Lake Street had already fully exercised the over-allotment option for two-year milestone warrants, five-year milestone warrants covering 6,403,290 shares or pre-funded warrants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AEON Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001837607-26-000055), on July 23, 2026, and is solely responsible for the information contained therein.